Genetic variation of Neurogenin 3 is slightly associated with hyperproinsulinaemia and progression toward type 2 diabetes

被引：8

作者：

Li, J. ^{[1
]}

Bergmann, A.

Reimann, M. ^{[1
]}

Schulze, J. ^{[1
]}

Bornstein, S. R. ^{[1
]}

Schwarz, P. E. H. ^{[1
]}

机构：

[1] Tech Univ Dresden, Med Fac Carl Gustav Carus, Med Clin 3, Dept Endocrinopathies & Metab Dis, D-01309 Dresden, Germany

来源：

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 2008年 / 116卷 / 03期

关键词：

Neurogenin; 3; proinsulin; progression of type 2; diabetes;

D O I：

10.1055/s-2007-992156

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: Transcription factor Neurogenin 3 (NGN3) is considered as a candidate gene for the development of type 2 diabetes. The aim of the current study was to investigate the relevance of NGN3 variants for the clinical spectrum of diabetes development and disease progressions. Research Design and Methods: A total of 552 subjects with increased risk of type 2 diabetes were investigated. They underwent a 75g OGTT with measurements of plasma glucose, insulin and proinsulin at fasting and at 30, 60,90 and 120 minutes after the glucose challenge, repeated after 3 years. The NGN3 SNPs, Gly167Arg and Ser199Phe were genotyped. Result: Patients with type 2 diabetes carrying the variant genotype at SNP199 presented with significantly higher proinsulin levels. Proinsulin level was also associated with progression of diabetes mellitus. There was a discrete association of the Ser199Phe variant with evolution of the disease status. Conclusion: A genetic variation in NGN3 gene may be among the genetic determinants involved in the pathogenesis of diabetes.

引用

页码：178 / 183

页数：6

共 42 条

[1] Notch signalling controls pancreatic cell differentiation [J].

Apelqvist, Å ;

Li, H ;

Sommer, L ;

Beatus, P ;

Anderson, DJ ;

Honjo, T ;

de Angelis, MH ;

Lendahl, U ;

Edlund, H .

NATURE, 1999, 400 (6747) :877-881

[2]

Borch-Johnsen K, 1999, LANCET, V354, P617

[3] 150 years of Sigmund Freud: what would Freud have said about the obesity epidemic? [J].

Bornstein, S. R. ;

Wong, M. -L. ;

Licinio, J. .

MOLECULAR PSYCHIATRY, 2006, 11 (12) :1070-1072

[4] Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions [J].

Bornstein, S. R. ;

Schuppenies, A. ;

Wong, M. -L. ;

Licinio, J. .

MOLECULAR PSYCHIATRY, 2006, 11 (10) :892-902

[5]

BOSQUEPLATA L, 2001, DIABETES, V50, P694

[6] Behavioral science research in the prevention of diabetes - Status and opportunities [J].

Fisher, EB ;

Walker, EA ;

Bostrom, A ;

Fischhoff, B ;

Haire-Joshu, D ;

Johnson, SB .

DIABETES CARE, 2002, 25 (03) :599-606

[7] neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas [J].

Gradwohl, G ;

Dierich, A ;

LeMeur, M ;

Guillemot, F .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1607-1611

[8] Quantitative evaluation of a monoclonal antibody and its fragment as potential markers for pancreatic beta cell mass [J].

Hampe, CS ;

Wallen, AR ;

Schlosser, M ;

Ziegler, M ;

Sweet, IR .

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (07) :381-387

[9] Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus [J].

Hani, EH ;

Stoffers, DA ;

Chèvre, JC ;

Durand, E ;

Stanojevic, V ;

Dina, C ;

Habener, JF ;

Froguel, P .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (09) :R41-R48

[10] Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium [J].

Jenny, M ;

Uhl, C ;

Roche, C ;

Duluc, I ;

Guillermin, V ;

Guillemot, F ;

Jensen, J ;

Kedinger, M ;

Gradwohl, G .

EMBO JOURNAL, 2002, 21 (23) :6338-6347

← 1 2 3 4 5 →